Scedosporium apiospermum: a fungal pathogen causing pneumonia in a patient with cystic fibrosis

References

1. Aaron S. D., Vandemheen K. L., Freitag A., Pedder L., Cameron W., Lavoie A., Paterson N., Wilcox P., Rabin H.. other authors 2012; Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study. PLoS One 7: e36077 [CrossRef]
   [Google Scholar]
2. Amin R., Dupuis A., Aaron S. D., Ratjen F.. 2010; The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 137: 171– 176 [CrossRef]
   [Google Scholar]
3. Ashbee H. R., Barnes R. A., Johnson E. M., Richardson M. D., Gorton R., Hope W. W.. 2014; Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother 69: 1162– 1176 [CrossRef]
   [Google Scholar]
4. Bernhardt A., Sedlacek L., Wagner S., Schwarz C., Würstl B., Tintelnot K.. 2013; Multilocus sequence typing of Scedosporium apiospermum Pseudallescheria boydii isolates from cystic fibrosis patients. J Cyst Fibros 12: 592– 598 [CrossRef]
   [Google Scholar]
5. Bertrand S., Larcher G., Landreau A., Richomme P., Duval O., Bouchara J. P.. 2009; Hydroxamate siderophores of Scedosporium apiospermum. Biometals 22: 1019– 1029 [CrossRef]
   [Google Scholar]
6. Brown K., Rosenthal M., Bush A.. 1999; Fatal invasive aspergillosis in an adolescent with cystic fibrosis. Pediatr Pulmonol 27: 130– 133 [CrossRef]
   [Google Scholar]
7. Clinical and Laboratory Standards Institute.. ( 2008; Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, approved standard – 2nd ed., M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute.
   [Google Scholar]
8. Cohen T. S., Prince A.. 2012; Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med 18: 509– 519 [CrossRef]
   [Google Scholar]
9. Eickmeier O., Rieber N., Eckrich J., Hector A., Graeppler-Mainka U., Hartl D.. 2013; Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease. Curr Pharm Des 19: 3669– 3678 [CrossRef]
   [Google Scholar]
10. Garré M., laLabarthe B., Kombila-Favry M., Thomas R., Launois B., Cartier F.. 1975; [Pneumocystis carinii pneumonia after kidney transplantation. Early diagnosis by distal bronchial brushing]. Nouv Presse Med 4: 393– 394 (in French)
    [Google Scholar]
11. Hartl D., Gaggar A., Bruscia E., Hector A., Marcos V., Jung A., Greene C., McElvaney G., Mall M., Döring G.. 2012; Innate immunity in cystic fibrosis lung disease. J Cyst Fibros 11: 363– 382 [CrossRef]
    [Google Scholar]
12. Holle J., Leichsenring M., Meissner P. E.. 2014; Nebulized voriconazole in infections with Scedosporium apiospermum – case report and review of the literature. J Cyst Fibros 13: 400– 402 [CrossRef]
    [Google Scholar]
13. Horré R., Marklein G., Siekmeier R., Nidermajer S., Reiffert S. M.. 2009; Selective isolation of Pseudallescheria Scedosporium species from respiratory tract specimens of cystic fibrosis patients. Respiration 77: 320– 324 [CrossRef]
    [Google Scholar]
14. Knutsen A. P., Hutcheson P. S., Slavin R. G., Kurup V. P.. 2004; IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Allergy 59: 198– 203 [CrossRef]
    [Google Scholar]
15. Larcher G., Cimon B., Symoens F., Tronchin G., Chabasse D., Bouchara J. P.. 1996; A 33 kDa serine proteinase from Scedosporium apiospermum. Biochem J 315: 119– 126
    [Google Scholar]
16. Lobo L. J., Noone P. G.. 2014; Respiratory infections in patients with cystic fibrosis undergoing lung transplantation. Lancet Respir Med 2: 73– 82 [CrossRef]
    [Google Scholar]
17. Mastella G., Rainisio M., Harms H. K., Hodson M. E., Koch C., Navarro J., Strandvik B., McKenzie S. G.. & The Investigators of the Epidemiologic Registry of Cystic Fibrosis 2000; Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Eur Respir J 16: 464– 471 [CrossRef]
    [Google Scholar]
18. Ostrosky-Zeichner L.. 2012; Invasive mycoses: diagnostic challenges. Am J Med 125: S14– S24 [CrossRef]
    [Google Scholar]
19. Parize P., Billaud S., Bienvenu A. L., Bourdy S., le Pogam M. A., Reix P., Picot S., Robert R., Lortholary O.. & other authors 2014a; Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis. J Cyst Fibros 13: 667– 673 [CrossRef]
    [Google Scholar]
20. Parize P., Billaud S., Bienvenu A. L., Bourdy S., le Pogam M. A., Reix P., Picot S., Robert R., Lortholary O.. & other authors 2014b; Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis. J Cyst Fibros 13: 667– 673 [CrossRef]
    [Google Scholar]
21. Pihet M., Carrere J., Cimon B., Chabasse D., Delhaes L., Symoens F., Bouchara J. P., Pihet M., Carrere J.. & other authors 2009; Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis – a review. Med Mycol 47: 387– 397 [CrossRef]
    [Google Scholar]
22. Rainer J., Kaltseis J., de Hoog S. G., Summerbell R. C.. 2008; Efficacy of a selective isolation procedure for members of the Pseudallescheria boydii complex. Antonie van Leeuwenhoek 93: 315– 322 [CrossRef]
    [Google Scholar]
23. Sedlacek L., Graf B., Schwarz C., Albert F., Peter S., Würstl B., Wagner S., Klotz M., Becker A.. & other authors 2015; Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium. J Cyst Fibros 14: 237– 241 [CrossRef]
    [Google Scholar]
24. Slavin R. G., Hutcheson P. S., Chauhan B., Bellone C. J.. 2004; An overview of allergic bronchopulmonary aspergillosis with some new insights. Allergy Asthma Proc 25: 395– 399
    [Google Scholar]
25. Slavin M., van Hal S., Sorrell T. C., Lee A., Marriott D. J., Daveson K., Kennedy K., Hajkowicz K., Halliday C.. & other authors 2015; Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality. Clin Microbiol Infect [Epub ahead of print]
    [Google Scholar]
26. Stenbit A. E., Flume P. A.. 2011; Pulmonary exacerbations in cystic fibrosis. Curr Opin Pulm Med 17: 442– 447
    [Google Scholar]
27. Zouhair R., Rougeron A., Razafimandimby B., Kobi A., Bouchara J. P., Giraud S.. 2013; Distribution of the different species of the Pseudallescheria boydii/Scedosporium apiospermum complex in French patients with cystic fibrosis. Med Mycol 51: 603– 613 [CrossRef]
    [Google Scholar]